Key facts
- It has raised $240K; the latest was Early Stage VC in Jan 2025.
- Notable investors include SFC Capital, Dublin City Council, Singular Link.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Evolve Neuro
- ·The full record, as it builds
Funding rounds
No funding rounds for Evolve Neuro are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Evolve Neuro
Operator of a brain technology company intended to improve their personal and professional performance. The company specializes in supporting elite athletes through remote brain mapping, personalized brain training programs, and performance assessment to precisely localize problem areas in the brain, enabling clients to identify suboptimal brain areas and improve the work capacity of the brain.
- Sector
- Business Products and Services (B2B)
- HQ
- Dublin, Ireland
- Founded
- 2022
- Employees
- 16
- Website
- evolveneuro.ai/
- Ownership
- Privately Held (backing)
Evolve Neuro doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Evolve Neuro shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Evolve Neuro in its N-PORT filings yet. We sweep new filings monthly.